DMRA Damora Therapeutics, Inc.
$20.66
Damora Therapeutics, Inc. (DMRA) Seasonality
What this stock has historically done over the three months following this point in the calendar year, measured against every other three-month stretch on record.
Not enough price history for DMRA to build a seasonal study.